Thomas J. van Haarlem

InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Medco Health Solutions, Inc. retails drugs, pharmaceuticals and other health products through online. The firm provides pharmacy services which are designed for private and public employers, health plans, labor unions government agencies of all sizes and individuals. The company was founded in June 1983 and is headquartered in Franklin Lakes, NJ.

Part of Sarepta Therapeutics, Inc., Immunotherapy Corp. develops cancer treatments. The company is based in Seattle, WA. The CEO of the company is Amnon Gonenne. Immunotherapy was acquired by AntiVirals, Inc. on November 06, 1997 for $24 million.

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

The West Virginia University Foundation, Inc. provides financial support to charitable causes. The company's services include fund raising and management of the assets of West Virginia University. It seeks support for faculty, programs, services, equipment, and facilities. The company was founded in 1954 and is headquartered in Morgantown, WV.

Part of Bausch Health Cos., Inc., B+L Diagnostics, Inc. is a company that manufactures and distributes biopharmaceuticals. The company is based in Warren Township, NJ. B+L Diagnostics was acquired by Bausch Health Cos., Inc. from Nicox SA on November 17, 2014 for $20 million.

Windamere Venture Partners LLC (Windamere Venture Partners) is an independent venture capital firm founded in 1999 by Scott L. Glenn. The firm is headquartered in San Diego.

Nomura Securities International, Inc. (NSI) is a registered broker/dealer headquartered in New York City and was founded in 1969. The firm is a division of Nomura Holding America, Inc. and their ultimate parent is Nomura Holdings, Inc. (NYSE: NMR, TYO: 8604, AMS: 8604). NSI provides securities brokerage services, as well as asset management, domestic retail, global markets, global investment banking and global merchant banking services. The firm's fixed-income business consists of bond sales and trading, origination and product supply for securitization deals and real estate-focused asset finance operations (in cooperation with Investment Banking). In the equity markets, NSI offers sales and trading of domestic and foreign stocks on a global basis, primarily for institutional investors.

JPMorgan Private Capital Asia Corp (JPMorgan Asia) is a private equity arm of JPMorgan Chase Co founded in 2006. The firm is headquartered in New York.

Breakthrough Energy Investment LLC (Breakthrough Energy Ventures) a venture capital arm of Breakthrough Energy LLC was founded in 2016 by Bill Gates. The firm is headquartered in Boston, Massachusetts.

Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA.

First Aid Beverages, Inc. develops and commercializes comprehensive portfolio of over-the-counter pharmaceutical products. It develops liquid formulated single-dose products for treating pain and upset stomach symptoms. The company was founded by Mary Page Platerink and Jay Pasricha in 2010 and is headquartered in Burlingame, CA.

Sofinnova Management VIII LLC is headquartered in Menlo Park, CA.

Amarin Pharma, Inc. operates as a biopharmaceutical research company. The company was founded in 2007 and is headquartered in Bedminster, NJ.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY.

Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA.

Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California.